M11-03: Natural agents for chemoprevention  by Surh, Young-joon
Journal of Thoracic Oncology • Volume 2, Number 8, Supplement 4, August 2007  12th World Conference on Lung Cancer
Copyright © 2007 by the International Association for the Study of Lung CancerS184
kinase inhibitors of the Epidermal Growth Factor Receptor (EGFR) and 
several other phytochemicals possess unique modes of action against 
cancer growth(4). On the other hand, the mode of action of several 
of these agents at the gene transcription level is not yet completely 
understood. Thanks to new molecular biological techniques this insight 
is rapidly increasing and after many years with meager results of che-
moprevention studies the way seems to be paved for a brighter future.
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I. Chemoprevention with Edible Phytochemicals
Chemoprevention is an attempt to use either naturally occurring or 
synthetic substances or their mixtures to intervene in the progress of 
carcinogenesis. A vast variety of phytochemicals present in our daily 
diet, including fruit, vegetables, grains, spices, and seeds, have been 
shown to possess substantial anti-mutagenic and anti-carcinogenic ac-
tivities. The chemopreventive effects that most edible phytochemicals 
exerts are likely to be the sum of several distinct mechanisms. These 
include blockage of metabolic activation and DNA binding of carcino-
gens, stimulation of detoxiﬁcation, repair of DNA damage, suppression 
of cell proliferation and metastasis or angiogenesis, induction of dif-
ferentiation or apoptosis of precancerous or maliganant cells, etc. (1). 
Recently, it has been known that common dietary chemicals act on the 
human genome, either directly or indirectly, to alter gene expression, 
thereby regulating carcinogenic processes. Fig. 1 illustrates the chemi-
cal structures of some representative chemopreventive phytochemicals 
and their dietary sources.
II. Intracellular Signal Network as a Novel Target for  
Chemoprevention
Research directed toward elucidating molecular mechanisms underly-
ing chemopreventive or chemoprotective actions of dietary phytochem-
icals has recognized components of signal transduction pathways as 
potential targets. Since the cellular signaling network often goes awry 
in carcinogenesis, it is fairly rational to target intracellular signaling 
cascades for achieving chemoprevention (1). Numerous molecules and 
events are involved in relaying intracellular signals. Both external and 
endogenous stimuli turn on or switch off critical events of this relay, 
thereby transmitting proper signaling to diverse downstream target 
molecules in a highly sophisticated fashion for ﬁne-tuning of cel-
lular homeostasis. Components of upstream or cytoplasmic signaling 
networks include protein kinases, such as the family of proline-directed 
serine/threonine kinases named mitogen-activated protein (MAP) 
kinases, protein kinase C, phosphatidylinositol-3-kinase, protein kinase 
B/Akt, glycogen synthase kinase, etc. 
Figure 1. Representative chemopreventive phytochemicals and their dietary 
sources. Source: Surh, Y.-J. (2003) Nature Rev. Cancer
A new horizon in chemoprevention research is the recent discovery of 
molecular links between inﬂammation and cancer (2). Components of 
the cell signaling network, especially those converge on the ubiquitous 
eukaryotic redox-sensitive transcription factor, nuclear factor-kappaB 
(NF-κB), have been implicated in pathogenesis of many inﬂamma-
tion-associated disorders. Modulation of cellular signaling involved 
in chronic inﬂammatory response by anti-inﬂammatory agents hence 
provides a rational and pragmatic strategy in molecular target-based 
chemoprevention and cytoprotection (3). Induction of phase-2 detoxify-
ing or antioxidant genes represents an important cellular defence in re-
sponse to oxidative and electrophilic insults. Nuclear transcription fac-
tor erythroid 2p45 (NF-E2)-related factor 2 (Nrf2) plays a crucial role 
in regulating phase-2 detoxifying/antioxidant gene induction. Many 
antioxidants derived from dietary and medicinal plants have been found 
to activate this particular redox-sensitive transcription factor, thereby 
potentiating cellular antioxidant or detoxiﬁcation capacity (4,5). It is 
noteworthy that there is a good correlation between anti-inﬂammatory 
activity of some chemopreventive/ cytoprotective agents and their abil-
ity to induce antioxidant gene expression (6). 
III. Anti-inﬂammatory and Antioxidant Phytochemicals Targeting 
NF-κB or Nrf2 
The current research in my laboratory concerns evaluation of various 
chemopreventive effects of some edible antioxidative and anti-inﬂam-
matory phytochemicals and elucidation of their underlying molecular 
mechanisms. Our research program has attempted to unravel common 
events mediated by transcription factors, such as NF-κB and Nrf2, and 
upstream kinases involved in the cellular signaling network for molecu-
lar target-based chemoprevention with selected dietary and medicinal 
phytochemicals (1). Curcumin, a yellow coloring agent contained in 
turmeric (Curcuma longa L., Zingiberaceae), has been reported to 
possess strong anti-tumor promotional as well as anti-inﬂammatory 
and antioxidant activities. Our recent studies have demonstrated that 
curcumin inhibits expression of cyclooxygenase-2 (COX-2) in mouse 
skin treated with the tumor promoter 12-O-tetradecanoylphorbol-13-
acetate (TPA) through inactivation of the eukaryotic transcription factor 
NF-κB. Inhibition of NF-κB by curcumin appears to be mediated by 
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blocking ERK1/2 and p38 MAP kinases (7). [6]-Gingerol, a pungent 
ingredient present in ginger (Zingiber ofﬁcinale Roscoe, Zingiberaceae), 
inhibited TPA-induced tumor necrosis factor-alpha production, ornithine 
decarboxylase activity, and skin tumor promotion in female ICR mice 
(8). Topically applied [6]-gingerol inhibited TPA-induced phosphoryla-
tion of p65 at Ser 536 and its interaction with the coactivator cAMP 
response element binding protein-binding protein(CBP/p300) in mouse 
skin, thereby rendering NF-κB transcriptionally inactive (9). The NF-κB 
inhibitory effects of [6]-gingerol appears to be associated with inhibition 
of p38 MAP kinase. [6]-Gingerol also inhibited anchorage-indepen-
dent growth of mouse epidermal JB-6 cells stimulated with epidermal 
growth factor (10). Capsaicin, a major pungent principle of hot chili 
pepper (Capsicum annuum L., Solanaceae) with potential anti-inﬂam-
matory and anti-tumor promoting properties, also suppressed TPA-in-
duced activation of NF-κB in mouse skin in vivo (11). It also induces 
apoptosis in cancerous cells (12). Resveratrol, a phytoalexin present in 
grapes and red wine, inhibited TPA-induced phosphorylation of IκBα 
and subsequent p65 nuclear translocation by blocking IKKα and IKKβ 
(13). It also blocked the TCDD-induced expression of CYP1A1 and 
CYP1A2 in MCF10A cells, thereby reducing the formation of catechol 
estrogens from 17-beta estradiol (14). A recent study from my labora-
tory has revealed that resveratrol protects against oxidative PC12 cells 
by inducing Nrf2-driven expression of heme oxygenase-1 (15). The 
green tea polyphenol EGCG also inhibited activation of NF-κB and AP-
1 thereby suppressing the COX-2 induction in mouse skin in vivo and/or 
cultured human mammary epithelial (MCF10A) cells (16). EGCG also 
upregulated antioxidant enzymes by activating the Nrf2-ARE signal-
ing pathway. Cysteine thiols present in various transcription factors and 
their regulators are recognized to function as redox sensors involved 
in ﬁne-tuning of transcriptional regulation of many genes essential for 
maintaining cellular homeostasis. Thus, oxidation or covalent modiﬁca-
tion of thiol groups present in redox-sensitive transcription factors and 
their regulating molecules can provide a unique strategy for molecular 
target-based chemoprevention and cytoprotection with anti-inﬂamma-
tory and antioxidant phytochemicals (17,18). 
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Lung cancer has been the most common cancer worldwide since 1985. 
It is the leading cause of cancer death in the world. Close to 90% of 
lung cancers are caused by tobacco smoking. Smoking cessation un-
fortunately does not eliminate the risk of lung cancer. In fact, over 50% 
of newly diagnosed lung cancers are now found in former smokers. 
The lack of effective therapy underscores the urgency to explore new 
frontiers of management, such as chemoprevention. Chemoprevention 
refers to the use of speciﬁc agents to reverse, suppress, or prevent the 
process of carcinogenesis. 
Based on epidemiological or preclinical data, several phase III lung 
cancer chemoprevention trials involving beta-carotene, vitamin A, 
E, 13-cis retinoic acid and N-acetylcysteine had been conducted but 
none had demonstrated beneﬁcial results. To facilitate the evaluation 
of promising agents, focus is now turning toward phase II studies 
with assessment of surrogate endpoint biomarkers (SEBM) of lung 
carcinogenesis. With understanding of important cellular signaling 
pathways involved in malignant transformation, various agents capable 
of modulating carcinogenic pathways are currently under active 
investigation. This presentation summarizes ongoing chemopreventive 
trials sponsored by the National Cancer Institute, many of which entail 
modulations of the ecosanoid signaling pathway, with a focus on stud-
ies involving COX-2 inhibition.
Eicosanoids are lipid metabolites that derive their names from their 
common origin, the eicosaenoic acids, which are C20 polyunsaturated 
